Nanofluidics-based DNA Screening Device
Award last edited on: 1/11/06

Sponsored Program
Awarding Agency
Total Award Amount
Award Phase
Solicitation Topic Code

Principal Investigator
Stephen W Turner

Company Information

Pacific Biosciences of California Inc (AKA: NFI~Nanofluidics Inc~Pacific Biosciences~PacBio)

1380 Willow Road
Menlo Park, CA 94025
Location: Single
Congr. District: 18
County: San Mateo

Phase I

Contract Number: 1R43HG002548-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
Phase I Amount
A nanofluidic DNA screening device for cancer-related diagnosis and research will be developed. Point mutations and single nucleotide polymorphisms will be detected optically using fluorescent hybridization probes on a fully stretched strand of chromosomal DNA as it passes through a nanoscale tube. Array-based methods for detecting single-base differences have been demonstrated, but the fluidics method proposed here has several advantages, including immunity to coincidental sequence repeats, superior detection of rare mutations in mixed samples, and the retention of correlations between different loci on the same chromosome. Fluidics-based methods for screening genetic content have been studied before (Austin 1999), but have been limited by the methods of fluidics fabrication employed. For this device, a sacrificial layer technique for fabricating fluidics has been developed which allows precise control of complex fluid circuits with nanoscale dimensions (Turner 1998). A tube smaller than the persistence length of double-stranded DNA will prevent the molecule from folding back on itself while passing through the tube, thus eliminating the primary source of error in previous attempts to implement this method.

Thesaurus Terms:
DNA, biomedical equipment development, fluid flow, genetic polymorphism, genetic screening, nanotechnology, point mutation genome biotechnology

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
Phase II Amount